Kaiser Foundation Health Plan Northern California
hydroxyurea (hydroxyurea)
Drugs for Cancer : Drugs for Cancer
  • Acute Myeloid Leukemia:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Drug Policy Based On: Payer Specific
    Quantity Limit: N/A
    Diagnosis Types: All FDA-approved indications
    Excludes Coverage in Maintenance Setting: No